Winston J Churchill Baudax Bio, Inc. (BXRX) insider trading activity

Winston J Churchill is Director of Baudax Bio, Inc.. Currently has a direct ownership of 46,820 shares of BXRX, which is worth approximately $468. The most recent transaction as insider was on Jun 15, 2022, when has been sold 39,473 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 46.8K

0% 3M change

0% 12M change

Total Value Held $468

WINSTON J CHURCHILL Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 15 2022	BUY Grant, award, or other acquisition	-	39,473 Added 45.74%	46,820 Common Stock
Aug 31 2021	BUY Open market or private purchase	$63,000 $0.63 p/Share	100,000 Added 28.0%	257,185 Common Stock
Jun 07 2021	BUY Open market or private purchase	$19,500 $0.78 p/Share	25,000 Added 13.72%	157,185 Common Stock
Apr 07 2021	BUY Grant, award, or other acquisition	-	56,452 Added 29.93%	132,185 Common Stock

Also insider at

AMKR

AMKOR TECHNOLOGY, INC. Technology

Director

ISSC

INNOVATIVE SOLUTIONS & SUPPORT INC Industrials

REPH

Societal CDMO, Inc. Healthcare

Director

WJC